{
    "clinical_study": {
        "@rank": "82262", 
        "arm_group": {
            "arm_group_label": "1, 25 dihydroxyvitamin D3 intake", 
            "arm_group_type": "Experimental", 
            "description": "This is a single arm study."
        }, 
        "brief_summary": {
            "textblock": "The study is conducted to assess the effect of a vitamin D3 supplementation on the\n      activities of two intestinal transporters and on the pharmacokinetics of the transporter\n      substrates folic acid and fexofenadine.\n\n        -  Trial with medicinal product"
        }, 
        "brief_title": "Vitamin D3, Folic Acid and Fexofenadine in Healthy Volunteers", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Physiological Effects of Vitamin D", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          1. male or female\n\n          2. age 18 to 65 years at study entry\n\n          3. signed informed consent form\n\n          4. Body Mass Index > 18 - < 30 kg/m2\n\n          5. Participants must not have any other diseases (as assessed by the screening\n             examination)\n\n          6. Participants must not take any concomitant medications except oral contraceptives in\n             females\n\n          7. Normal blood count\n\n        Exclusion criteria:\n\n          1. Subjects with confirmed or suspected hypersensitivity towards the study medications\n\n          2. Contemporaneous participation in any other study\n\n          3. Females only: pregnancy\n\n          4. Females only: breast-feeding\n\n          5. Clinically significant abnormal laboratory findings\n\n          6. Known or suspected present or past malignancies of any kind\n\n          7. Known or suspected active infections, serious infections in the preceding 3 months\n\n          8. Positive hepatitis B, hepatitis C and / or HIV 1/2 serology\n\n          9. Subjects known or suspected not to comply with the study regulations\n\n         10. Subjects employed at the participating departments of the University Hospital Z\u00fcrich.\n\n         11. Known or suspected present or past diseases which may interfere with the study\n\n         12. smokers\n\n         13. alcohol or drug abuse"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01856348", 
            "org_study_id": "PHA-11-VID/FOL-01"
        }, 
        "intervention": {
            "arm_group_label": "1, 25 dihydroxyvitamin D3 intake", 
            "intervention_name": "Vitamin D", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Calcitriol", 
                "Cholecalciferol", 
                "Dihydroxycholecalciferols", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Folic Acid", 
                "Vitamins", 
                "Vitamin B Complex", 
                "Fexofenadine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 9, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Zurich", 
                    "country": "Switzerland", 
                    "state": "ZH", 
                    "zip": "8091"
                }, 
                "name": "University Hospital Zurich, Dept. of Clinical Pharmacology and Toxicology"
            }
        }, 
        "location_countries": {
            "country": "Switzerland"
        }, 
        "number_of_arms": "1", 
        "official_title": "Effects of Vitamin D3 (1,25 Dihydroxyvitamin D3) on Pharmacokinetics and Absorption of Folic Acid and Fexofenadine in Healthy Volunteers", 
        "overall_official": {
            "affiliation": "University Hospital Zurich, Pharmacology and Toxicology", 
            "last_name": "Gerd A Kullak-Ublick, Prof MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Switzerland: Swissmedic", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "description": "Changes in single-dose pharmacokinetics of racemic fexofenadine at the end of a substitution with 1,25 dihydroxyvitamin D3 in comparison to pharmacokinetics before the substitution.", 
                "measure": "Ratio of the area under the concentration vs. time curve (AUC) of fexofenadine after vitamin D over AUC of fexofenadine before vitamin D", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }, 
            {
                "description": "Changes in single-dose pharmacokinetics of folic acid at the end of a substitution with 1,25 dihydroxyvitamin D3 in comparison to pharmacokinetics before the substitution.", 
                "measure": "Ratio of Area under the concentration vs. time curve (AUC) of folic acid after vitamin D over AUC of folic acid before vitamin D", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01856348"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Number and characteristics of participants with adverse events", 
                "safety_issue": "Yes", 
                "time_frame": "10 days"
            }, 
            {
                "description": "Comparison of transporter mRNA levels after ten days of vitamin D3 intake in comparison to the levels before intake.", 
                "measure": "transporter mRNA quantity", 
                "safety_issue": "No", 
                "time_frame": "10 days"
            }
        ], 
        "source": "University of Zurich", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Zurich", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}